EP 0885294 A2 19981223 - CARDIOTROPHIN AND USES THEREFOR
Title (en)
CARDIOTROPHIN AND USES THEREFOR
Title (de)
CARDIOTROPHIN UND VERWENDUNG DAVON
Title (fr)
CARDIOTROPHINE ET SES UTILISATIONS
Publication
Application
Priority
- US 9702675 W 19970211
- US 60139596 A 19960214
Abstract (en)
[origin: WO9730146A2] Isolated CT-1, isolated DNA encoding CT-1, and recombinant or synthetic methods of preparing CT-1 are disclosed. CT-1 is shown to bind to and activate the receptor, LIFR beta . These CT-1 molecules are shown to influence hypertrophic activity, neurological activity, and other activities associated with receptor LIFR beta . Accordingly, these compounds or their antagonists may be used for treatment of heart failure, arrhythmic disorders, inotropic disorders, neurological disorders, and other disorders associated with the LIFR beta .
IPC 1-7
IPC 8 full level
A61K 38/19 (2006.01); C12N 5/0735 (2010.01)
CPC (source: EP)
A61K 35/34 (2013.01); A61K 38/204 (2013.01); A61P 15/06 (2017.12); A61P 25/00 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); C12N 5/0606 (2013.01); C12N 2501/115 (2013.01); C12N 2501/125 (2013.01); C12N 2501/175 (2013.01)
Citation (search report)
See references of WO 9730146A2
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9730146 A2 19970821; WO 9730146 A3 19971009; AU 1965497 A 19970902; AU 733403 B2 20010510; EP 0885294 A2 19981223; IL 125548 A0 19990312; IL 125548 A 20040725; JP 2000504729 A 20000418; ZA 971226 B 19980813
DOCDB simple family (application)
US 9702675 W 19970211; AU 1965497 A 19970211; EP 97907730 A 19970211; IL 12554897 A 19970211; JP 52960197 A 19970211; ZA 971226 A 19970213